Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Clinical trial NCT04543916 · WITHDRAWN

Trial details

NCT number: NCT04543916
Sponsor: Virginia Commonwealth University
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Small Cell Lung Cancer Refractory Small Cell Lung Carcinoma

Start date: 2021-06-30
Primary completion: 2028-05-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.